1. Wallace S, Keightley A, Gie C. Dysmenorrhoea. Obstet Gynaecol. 2010;12:149–54.
2. Borgelt LM, O’Connell MB, Smith JA, et al. Women’s health across the lifespan: a pharmacotherapeutic approach. Bethesda: American Society of Health-System Pharmacists; 2010.
3. Akerlund M, Stromberg P, Forsling MD. Primary dysmenorrhea and vasopressin. Br J Obstet Gynaecol. 1979;86:484.
4. Melin P, Akerlund M, Vilhardt H. Antagonism of the myometrial response to oxytocin and vasopressin synthetic analgesics. Dan Med Bull. 1979;26:126.
5. Demers LM, Hahn DW, McGuire JL. Newer concepts in dysmenorrhea research: leukotrienes and calcium channel blockers. In: Dawood MY, McGuire JL, Demers LM, editors. Premenstrual syndrome and dysmenorrhea. Baltimore: Urban & Schwarzenberg; 1985. p. 205.